Summit Therapeutics reports survival benefit for cancer drug in trial
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
Bon Secours Nears $6B Takeover of Surgery Partners: FT
Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners, valuing the group at about $20 a share, the Financial Times reports, citing people familiar with the…
Uganda orders 21-day Ebola quarantine for citizens returning from DR Congo
Kampala says country is Ebola free, but Swiss authorities believe a woman diagnosed in Nigeria was infected in Uganda.
Bon Secours nears $6bn takeover of Bain-backed Surgery Partners
US hospital chain is the latest not-for-profit healthcare provider to seek a large deal
NCDC to pay quarantined Ebola contacts N100,000 weekly
The Nigeria Centre for Disease Control and Prevention (NCDC) says it has approved a weekly allowance of N100,000 per person
Young adults with cancer report putting off appointments, getting dismissed by doctors
When Natasha Allard's close friend Dave was diagnosed with stage 4 testicular cancer at age 26, the University at Buffalo postdoctoral associate started paying more attention to how cancer was…